Europe - FRA:SHL - DE000SHL1006 - Common Stock
The current stock price of SHL.DE is 49.53 EUR. In the past month the price increased by 9.46%. In the past year, price decreased by -3.49%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 25.46 | 190.51B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 68.18 | 169.63B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 57.72 | 143.61B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 35.98 | 130.10B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.39 | 106.40B | ||
| 2M6.DE | MEDTRONIC PLC | 16.85 | 103.08B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.01 | 45.89B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 29.69 | 38.70B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.22 | 23.88B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.3 | 23.99B | ||
| DC4.DE | DEXCOM INC | 41.76 | 24.07B | ||
| QS51.DE | STRAUMANN HOLDING AG-REG | 34.12 | 15.51B |
Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. The company is headquartered in Forchheim, Bayern and currently employs 73,500 full-time employees. The company went IPO on 2018-03-16. The firm is a global provider of healthcare products, solutions and services. The company also provides clinical consulting services and training and service offerings. The Company’s segments include Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers a software solutions to support the reading and structured reporting of diagnostic images from different modalities. The Diagnostics segment offers to healthcare providers in the fields of general laboratory, specialty laboratory, and point-of-care diagnostics. The Varian segment offers a portfolio of cancer care technologies and services and support oncology departments in hospitals and clinics. The Advanced Therapies segment consists of integrated products, services and solutions used in the treatment of diseases across multiple clinical fields.
SIEMENS HEALTHINEERS AG
Siemensstr. 3
Forchheim BAYERN DE
Employees: 73100
Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. The company is headquartered in Forchheim, Bayern and currently employs 73,500 full-time employees. The company went IPO on 2018-03-16. The firm is a global provider of healthcare products, solutions and services. The company also provides clinical consulting services and training and service offerings. The Company’s segments include Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers a software solutions to support the reading and structured reporting of diagnostic images from different modalities. The Diagnostics segment offers to healthcare providers in the fields of general laboratory, specialty laboratory, and point-of-care diagnostics. The Varian segment offers a portfolio of cancer care technologies and services and support oncology departments in hospitals and clinics. The Advanced Therapies segment consists of integrated products, services and solutions used in the treatment of diseases across multiple clinical fields.
The current stock price of SHL.DE is 49.53 EUR. The price increased by 0.34% in the last trading session.
SIEMENS HEALTHINEERS AG (SHL.DE) has a dividend yield of 2%. The yearly dividend amount is currently 0.95.
SHL.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 20.81. This is based on the reported non-GAAP earnings per share of 2.38 and the current share price of 49.53 EUR.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SHL.DE.
ChartMill assigns a technical rating of 5 / 10 to SHL.DE. When comparing the yearly performance of all stocks, SHL.DE is a bad performer in the overall market: 74.48% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE. SHL.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months SHL.DE reported a non-GAAP Earnings per Share(EPS) of 2.38. The EPS increased by 11.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.29% | ||
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| Debt/Equity | 0.66 |
27 analysts have analysed SHL.DE and the average price target is 61.88 EUR. This implies a price increase of 24.93% is expected in the next year compared to the current price of 49.53.
For the next year, analysts expect an EPS growth of 9.68% and a revenue growth 4.89% for SHL.DE